Institutional Ownership
Evogene Ltd
CUSIP M4119S187SHS NEWEVGNQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
15
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 456.6K | $351.6K |
| 2 | Jane Street Group, LLC | 18.5K | $14.2K |
| 3 | Xtx Topco Ltd | 12.7K | $9.8K |
| 4 | Two Sigma Securities, LLC | 12.5K | $9.6K |
| 5 | Daytona Street Capital LLC | 9.6K | $7.7K |
| 6 | Bnp Paribas Financial Markets | 9.1K | $7.0K |
| 7 | Ubs Group AG | 6.4K | $4.9K |
| 8 | Morgan Stanley | 3.9K | $3.0K |
| 9 | Steward Partners Investment Advisory, LLC | 505 | $389 |
| 10 | Federation Des Caisses Desjardins Du Quebec | 500 | $385 |